For cell immunofluorescence, 2 × 104 cells were seeded on each confocal dish and cultured for 1 day. Cells were fixed with 4% paraformaldehyde for 15 min at room temperature. After permeabilizing with 0.1% Triton X-100 or cold digitonin (Abcam) for 10 min and blocking with normal goat serum for 30 min, samples were incubated with primary antibodies overnight at 4 °C, including anti-TOM20 (clone F-10, Santa Cruz Biotechnology; BM4366, Boster), anti-PD-L1 (clone EPR19759, Abcam; LS-C754760, LifeSpan BioSciences; 2B11D11, Proteintech), anti-LAMP1 (clone D2D11, Cell Signaling Technology; clone 1D4B, Santa Cruz Biotechnology), anti-TGN46 (clone 1F6D5, Proteintech), anti-Calnexin (clone 2A2C6, Proteintech). The cells were washed with PBS-T for three times and incubated with secondary antibodies (Alexa Fluor Plus 555, Alexa Fluor Plus 488, Alexa Fluor Plus 647, Invitrogen) at room temperature for 1 h. Antifade Mounting Medium with DAPI (Beyotime) was used to mount the samples. The confocal images were then taken on Zeiss LSM 900 and Airyscan 2 confocal laser scanning microscope and analyzed with ZEN 2.3 software. For MitoTracker staining, cells were incubated with MitoTracker Deep Red dyes in complete medium at 37 °C for 30 min, then were removed of excess unbound dyes by washing twice. For tissue immunofluorescence, paraffin sections of patients with TNBC were baked at 60 °C for 30 min followed by deparaffinization and rehydration using xylene and graded ethanol. After EDTA (pH 8.0) antigen retrieval and endogenous peroxidase blockade as IHC staining methods mentioned above, the samples were permeabilized with 0.3% Triton for 30 min and blocked with normal goat serum for 30 min at room temperature. Primary antibodies targeting PD-L1, LAMP1 and TOM20 were incubated with samples overnight at 4 °C. After secondary antibody incubation for 1 h and DAPI incubation for 15 min, 0.3% Sudan black-B solution was used to quench spontaneous fluorescence for 20 min at room temperature followed by washing twice. The confocal images were then taken and analyzed.
Xie X.Q., Yang Y., Wang Q., Liu H.F., Fang X.Y., Li C.L., Jiang Y.Z., Wang S., Zhao H.Y., Miao J.Y., Ding S.S., Liu X.D., Yao X.H., Yang W.T., Jiang J., Shao Z.M., Jin G, & Bian X.W. (2023). Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria. Cell Research, 33(3), 215-228.
Other organizations :
Army Medical University, Southwest Hospital, Fudan University Shanghai Cancer Center, Shanghai Cancer Institute, Institute of Biophysics, Chinese Academy of Sciences
Cell permeabilization method (0.1% Triton X-100 or cold digitonin)
Primary antibodies used (anti-TOM20, anti-PD-L1, anti-LAMP1, anti-TGN46, anti-Calnexin)
dependent variables
Subcellular localization and expression of target proteins (TOM20, PD-L1, LAMP1, TGN46, Calnexin)
Mitochondrial staining with MitoTracker Deep Red dyes
control variables
Cell seeding density (2 × 10^4 cells per confocal dish)
Culture duration (1 day)
Fixation method (4% paraformaldehyde for 15 min)
Blocking with normal goat serum for 30 min
Secondary antibody incubation (1 h at room temperature)
Mounting with Antifade Mounting Medium with DAPI
Imaging with Zeiss LSM 900 and Airyscan 2 confocal laser scanning microscope
Analysis with ZEN 2.3 software
positive controls
Not specified
negative controls
Not specified
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required